November 20, 2019 marked the official close of our donor, Bristol-Myers Squibb's, acquisition of Celgene Corporation.
At this time, there are no changes to the patient assistance available from the Bristol-Myers Squibb Patient Foundation ("BMSPAF") or to the applicable eligibility criteria and terms and conditions for the BMSPAF. Patient assistance programs administered by Celgene are also unchanged at this time.
For patient assistance at Celgene, please call Celgene Patient Services at 1-800-931-8691.
For patient assistance at BMSPAF, please call (800) 736-0003.